课题基金 / 基金详情

项目摘要

项目成果

David Richard Hout的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): HIV-1/AIDS continues to be a global problem as no cure exists. While highly active anti-retroviral therapy is available to reduce viral loads in patients and delay the onset of disease, these treatments are costly, have numerous side effects and face a constantly mutating virus. Recently, some researchers have focused on the role cellular factors play on specific steps of HIV-1 replication in order to develop new targets for anti- retroviral therapy. One such new area of study focuses on the misunderstood process of HIV-1 core uncoating. Uncoating is defined specifically as the disassembly of the viral conical core and subsequent release of the viral genome. The Aiken laboratory has established that HIV-1 core disassembly is a highly sensitive process susceptible to small alterations in capsid stability. These alterations in core stability did not disrupt the conical structure but impaired reverse transcriptase activity and attenuated HIV-1 replication. The objective of this research is to identify the viral and cellular factors that play a role in core disassembly in order to achieve a better understanding of HIV-1 biology. This objective will be achieved by addressing three specific aims: 1. To identify a cellular factor that plays a role in HIV-1 core disassembly. 2. To determine the biological significance of this factor on HIV-1 infection. 3. To determine the role of core associated viral MA in HIV-1 uncoating and identify specific residues in MA responsible for uncoating. Completion of these three specific aims should open up a new area of research into the early post entry steps of HIV-1 replication with the possibility for identifying novel targets of anti-retroviral therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The roles od Elongation Factor 1 and Matrix in HIV-1 core disassembly
  • 批准号:
    7339913
  • 项目类别:
  • 资助金额:
    $4.68万
  • 财政年份:
    2007
  • 负责人:
    David Richard Hout
  • 依托单位:
海外基金